Tailored Exercise to Reduce Aromatase Inhibitor Associated Musculoskeletal Symptoms

Recruiting now · Not applicable

Conditions studied: Patients With Early Breast Cancer Who Initiating Adjuvant Aromatase Inhibitor

In brief

A randomized controlled study evaluating effect of tailored exercise compared to routine practice as a preventive measure of aromatase inhibitor associated musculoskeletal related symptoms in early breast cancer patients

Key facts

Study ID

NCT07448558

Run by

Mahidol University

People needed

206

Starts

2026-02-18

Expected to finish

2029-08-18

Last updated by the study team

2026-03-04

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• breast cancer patients with starting adjuvant aromatase inhibitor within 4 weeks
• able to read and write

You may not qualify if…

• chronic arthritis
• history of heart failure or acute coronary syndrome within 6 months
• individuals who exercises regularly more than 150 minutes/week

Where it is running

• Faculty of Medicine Siriraj Hospital, Mahidol University — Bangkok, Thailand (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.